Tyruko 61314-0543
Generic: Natalizumab-Sztn
Product NDC
61314-0543- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 17, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761322
Need to source Tyruko? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Natalizumab | 300 mg/15mL |
Drug Class
Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (61314-543-94) / 15 mL in 1 VIAL, SINGLE-DOSE